Barclays upgrades Keurig Dr Pepper to $32 target, citing strong brand, efficiency, and growth potential.

Barclays raised its price target for Keurig Dr Pepper to $32, citing confidence in the company’s brand strength, operational efficiency, and ability to adapt to shifting consumer trends. The firm highlighted KDP’s diversified beverage portfolio, disciplined cost management, and strategic investments in innovation and sustainability as key growth drivers. Despite macroeconomic headwinds, Barclays believes KDP’s pricing power and resilient demand support long-term performance. The upgrade reflects growing investor optimism about the company’s earnings potential and shareholder returns.